Proteinase-activated receptors 1 and 2 exert opposite effects on renal renin release

Hypertension

Volumn 58, Issue 4, 2011, Pages 611-618

  Höcherl, Klaus ^a   Gerl, Melanie ^a   Schweda, Frank ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

angiotensin; calcium; juxtaglomerular apparatus; NO; renin; thrombin

Indexed keywords

AMLODIPINE; BUMETANIDE; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; PROSTAGLANDIN E2; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; RENIN; THROMBIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUXTAGLOMERULAR APPARATUS; JUXTAGLOMERULAR CELL; KIDNEY PERFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN RELEASE; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOPROTERENOL; JUXTAGLOMERULAR APPARATUS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NITRIC OXIDE; OLIGOPEPTIDES; PYRROLES; QUINAZOLINES; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RENIN; THROMBIN;

EID: 80053574506     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.173229     Document Type: Article

References (34)

1. Shah R. Protease-activated receptors in cardiovascular health and diseases. Am Heart J. 2009;157:253-262.
2. Soh UJ, Dores MR, Chen B, Trejo J. Signal transduction by protease-activated receptors. Br J Pharmacol. 2010;160:191-203.
3. Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005;3:1800-1814. (Pubitemid 41716567)
4. Bertog M, Letz B, Kong W, Steinhoff M, Higgins MA, Bielfeld-Ackermann A, Fromter E, Bunnett NW, Korbmacher C. Basolateral proteinase-activated receptor (par-2) induces chloride secretion in m-1 mouse renal cortical collecting duct cells. J Physiol. 1999;521:3-17.
5. Gui Y, Loutzenhiser R, Hollenberg MD. Bidirectional regulation of renal hemodynamics by activation of par1 and par2 in isolated perfused rat kidney. Am J Physiol Renal Physiol. 2003;285:F95-F104. (Pubitemid 36818466)
6. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386:502-506. (Pubitemid 27164077)
7. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA. 1994;91:9208-9212. (Pubitemid 24297883)
8. Xu Y, Zacharias U, Peraldi MN, He CJ, Lu C, Sraer JD, Brass LF, Rondeau E. Constitutive expression and modulation of the functional thrombin receptor in the human kidney. Am J Pathol. 1995;146:101-110.
9. D'Andrea MR, Derian CK, Leturcq D, Baker SM, Brunmark A, Ling P, Darrow AL, Santulli RJ, Brass LF, Andrade-Gordon P. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem. 1998;46:157-164. (Pubitemid 28087846)
10. Castrop H, Hocherl K, Kurtz A, Schweda F, Todorov V, Wagner C. Physiology of kidney renin. Physiol Rev. 2010;90:607-673.
11. Stahl E, Karlberg BE, Rammer L. Fibrin deposition in the kidney and renal blood flow during intravascular coagulation in the rat: Influence of the renin-angiotensin system. Clin Sci (Lond). 1982;62:35-41. (Pubitemid 12191536)
12. Schweda F, Wagner C, Kramer BK, Schnermann J, Kurtz A. Preserved macula densa-dependent renin secretion in a1 adenosine receptor knockout mice. Am J Physiol Renal Physiol. 2003;284:F770-F777. (Pubitemid 36336984)
13. Hocherl K, Schmidt C, Kurt B, Bucher M. Inhibition of nf-kappab ameliorates sepsis-induced downregulation of aquaporin-2/v2 receptor expression and acute renal failure in vivo. Am J Physiol Renal Physiol. 2010;298: F196-F204.
14. Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation. 2006;114:1070-1077. (Pubitemid 44358884)
15. Trottier G, Hollenberg M, Wang X, Gui Y, Loutzenhiser K, Loutzenhiser R. Par-2 elicits afferent arteriolar vasodilation by no-dependent and no-independent actions. Am J Physiol Renal Physiol. 2002;282: F891-F897. (Pubitemid 34654496)
16. Ku DD, Dai J. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. J Cardiovasc Pharmacol. 1997;30:649-657. (Pubitemid 27524506)
17. Ku DD, Zaleski JK. Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. J Cardiovasc Pharmacol. 1993;22:609-616. (Pubitemid 23286758)
18. Godin D, Rioux F, Marceau F, Drapeau G. Mode of action of thrombin in the rabbit aorta. Br J Pharmacol. 1995;115:903-908.
19. Berk BC, Taubman MB, Griendling KK, Cragoe EJ Jr, Fenton JW, Brock TA. Thrombin-stimulated events in cultured vascular smooth-muscle cells. Biochem J. 1991;274:799-805.
20. Sacks RS, Firth AL, Remillard CV, Agange N, Yau J, Ko EA, Yuan JX. Thrombin-mediated increases in cytosolic [ca2] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;295:L1048-L1055.
21. Schweda F, Klar J, Narumiya S, Nusing RM, Kurtz A. Stimulation of renin release by prostaglandin e2 is mediated by ep2 and ep4 receptors in mouse kidneys. Am J Physiol Renal Physiol. 2004;287:F427-F433. (Pubitemid 39095956)
22. Schweda F, Segerer F, Castrop H, Schnermann J, Kurtz A. Blood pressure-dependent inhibition of renin secretion requires a1 adenosine receptors. Hypertension. 2005;46:780-786. (Pubitemid 43186753)
23. Kone BC. Localization and regulation of nitric oxide synthase isoforms in the kidney. Semin Nephrol. 1999;19:230-241. (Pubitemid 29200831)
24. Castrop H, Schweda F, Mizel D, Huang Y, Briggs J, Kurtz A, Schnermann J. Permissive role of nitric oxide in macula densa control of renin secretion. Am J Physiol Renal Physiol. 2004;286:F848-F857. (Pubitemid 38508985)
25. Moffatt JD, Cocks TM. Endothelium-dependent and-independent responses to protease-activated receptor-2 (par-2) activation in mouse isolated renal arteries. Br J Pharmacol. 1998;125:591-594. (Pubitemid 28482594)
26. Cicala C, Morello S, Vellecco V, Severino B, Sorrentino L, Cirino G. Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2. Cardiovasc Res. 2003;60:431-437. (Pubitemid 37412377)
27. Schweda F, Kurtz A. Cellular mechanism of renin release. Acta Physiol Scand. 2004;181:383-390. (Pubitemid 39078833)
28. Mack M, Rosenkranz AR. Basophils and mast cells in renal injury. Kidney Int. 2009;76:1142-1147.
29. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM. Gene expression of the renin-angiotensin system in human kidney. J Hypertens. 1998;16: 91-102. (Pubitemid 28069825)
30. Vesey DA, Hooper JD, Gobe GC, Johnson DW. Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology (Carlton). 2007;12:36-43.
31. Gabril M, White NM, Moussa M, Chow TF, Metias SM, Fatoohi E, Yousef GM. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Biol Chem. 2010;391:403-409.
32. Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Tumour Biol. 2006;27:1-7. (Pubitemid 41832698)
33. Yousef GM, Diamandis EP. The new kallikrein-like gene, klk-l2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J Biol Chem. 1999;274:37511-37516. (Pubitemid 30026803)
34. Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP. Cloning of a new member of the human kallikrein gene family, klk14, which is down-regulated in different malignancies. Cancer Res. 2001;61: 3425-3431. (Pubitemid 32695036)